Collaboration will unlock our potential and define our success.
The Physical Therapy Excellence Fellowship supports PTs in their research or clinical projects related to the care of patients with hemophilia.
This resource will provide much-needed guidance to emergency department personnel.
The impact of an FDA "Listening Session" on gene therapy for hemophilia.
ESPEROCT® is a long-acting recombinant product for the treatment of hemophilia A.
NHF maintains its prestigious 4-star rating from Charity Navigator, the largest independent charity evaluator in the US.
The organizations continue to monitor the outbreak.
The new guidance issued by the FDA seeks to support both innovation and patient safety.
The Hemophilia SNF Access Act will rectify a long-standing problem for Medicare beneficiaries with hemophilia and other bleeding disorders.
The summit was convened to address recent issues regarding recalls and product safety.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car